$XX.X revenue quarter year respectively, million for XXXX. pleased to year million call in quarter the to and and thank over for up and We you were full Thanks joining and million full $XX.X $X.X same to the the Debbie. in today. fourth million $XX.X results periods Shockwave's for everyone you Good reported XXXX I'm fourth us welcome XXXX. which review for the our afternoon
lithotripsy success strength encouraged our helping suffering complex or of be team vascular the solution educating field the improve IVL as our growing complex by unique intravascular for and for patients of adoption disease. and a calcified outcomes by patients with from continue We customers in to and calcification
provide will we year our the went but later few used over are to months. the IVL start ago. call, some going I'm less a transformed financials highlighting since in our bit by we seeing details update accomplishments also an will bit a than And Dan how on on of a which has past share public I
get to also the We will we ready our in launch U.S.. as coronary discuss plans some of
last our First our overview X.X, from the below-the-knee progress a limited were X.X commercial U.S. the of millimeter of that operational complement in including launched in X.X our release the December release this SX to in version quick launch and millimeter full a of a quarter. sizes market product X.X We to transitioned November.
make to signed our the Santa financing roughly a in on the to and U.S. in -- progress this IV Japan gross CAD III with continued the countries sold a good We which November. successful initiated We completed and second expanded facility Clara. space complete of our product We million. XX trial follow-on in course enrollment the CAD in We doubling for than over March. lease more study IDE geographically $XXX proceeds and we our year of expect
fronts our to globally. effectively efforts expand on team multiple we treat dedicated of to tell as As continues a patients spectrum broader our you can execute
really and use SX case. are early expanded We've of down seeing lower from below-the-knee. past of with leg satisfaction this diverse a up broad quarter, the every in the we limited pleased SX with traction launch level With very been and the of high use virtually
base a below-the-knee, disease safe limited XX% number there a annually calcification. of roughly XXX,XXX with and an procedures effective options treating are for area of range is There a where of
a to for believe is going this bed be where make to going we lithotripsy is patients. vessel impact significant a So
engage AT It's to or them to a the understand algorithm. calcified in areas where experience, high referred still of which incorporating carry best tibioperoneal into of such first, foot they provide a and single to and trunk single how using tibial vessels pattern down vessel small artery They early the there's recoil almost second, are third, treatment angioplasty; proximal SX technologies; launch other TPT the spots to we when as physicians risk their increase runoff. vessel often as flow standard where with after blood are: the emerging. branch only There complication arteries and remaining their is ankle or as sweet anterior at continue heavily both the and when the of to immediately
time diversification past below their of of knee over We six procedurements. lot a case meaningful In to underappreciation restoring flows are vessels commercial whether this determines a keep our or feels foot months SX discussing which an how more The even But to to of above-the-knee us. gets providing safely has for is not. the the what our reason. patient portfolio is good for of to opportunities led spent and like the it vessel addition
treat about cases everyone of So many treat. spectrum the like in vessels uniquely can I'd and to remind we
length the the behind the The thigh knee. then femoropopliteal arteries of and run
somewhat lesions than XXX,XXX tier to group treat are of we the in procedures of there subsegments. less the still most calcified vessels vessels being these close the largest other XX% this While about are peripheral with calcified of
bends a are avoid great despite this most physicians calcified for SFA volume the the IVL technology it's the at number the leg and in used of of and unique where to a most the helps is toughest lesions complications. the SFA which all gain in customers behind lumen of our risk of for movement use popliteal to large costs. is and of be the the the Given segment of where achieve IVL vessel no tends stents when all butter alternatives the almost The the procedure area bread segment. an is knee subset artery because deal great we and technologies want peripheral seeing
aspect safe the in minimal a be surgical is estimate is Approximately attractive there Femoral over of option. is common femoral bifurcated the annually CFA are low And lesions procedures and very dissection The of XX% proving Common segment So are between SFA. a to interventional internal short our just Artery pressure or the IVL above artery calcified. that approaches. XXX,XXX
Surgery a half common the been accounts and the vascular traditionally still opportunity is as separate this gold because surgical purview such preferred since standard long approach vessel physicians the or been profunda is considered compromising many stents remained atherectomy. the of when the for to want femoral because which blocking the they procedures. using endarterectomy risk The common or market options as has has has overlooked the femoral interventional avoid for nearly artery branch surgeon a
strongly safely lumen The the dilatation or iliacs. debris us are our surprise resonates with expand the that to embolic vessels have been the high-pressure without ability IVL's customers. most unanticipated for
dissections are can of treating indicate tricky. actually roughly cases calcified similarly be There great more And a iliacs data there perforation XX%. be XXX,XXX is safe calcified below-the-knee than iliac symptomatic are with iliac as managing options can Our a about that annually. for and number the even not since catastrophic procedures disease
prevents are a rupture. the and dissection event covering go-to calcified catastrophic the -- outcomes most of common stents option heavily or a in iliacs Covered in usually since the
and patent the can feed side pelvic that are since stents iliac However, covered blood compromise the the should expensive branches vessels ideally to remain area.
they major learned our risk using that and can non-covered the are of then crack Shockwave stent at very calcium covered letting and pressures customers having complication if and By up open follow low can minimal a have choose. either so the with iliac the IVL safely or they with
IVL. This the procedure the smallest numbers XX% segment the but access large-bore up catheter of large-bore cases iliacs nearly Lastly, with in of is still benefiting opportunity. potentially XXX,XXX to in is terms from
the the beauty procedure opportunities, large the number it everyone that as to is While Shockwave what benefit as profound bore offers. is large is not a obvious of other
versus better recognized more strategies safer TAVR most to that resort and and delivering committees to economical. Physicians importantly Patients, immediately access a just VAC is alternative transfemorally having
markets you scratched opportunity and surface. aggregate the calcified barely That's end an X difference. these in all a patients If with Shockwave make developed you have we enormous where up almost endovascular vessels million can
Shifting gears team. to field our
expansion to questions of the lot We a structure around future of planned of get and pace continue organization. the
will peripheral forward With device both techniques the very specialists and be of overlapping for force managers coronary use procedures. clinical peripheral responsible IVL a territory both all with confident for continue we are coronary sales to where customers physician and our and decision and single in
professionals in XXXX. perform we XX and XXXX way very organization a field team country. we doubling territory of ending nearly area U.S. the in with to And comprised continues in to The execute across XXX with XXX Our ended envision field managers clinical specialists and is managers. the the balanced
professionals We the sell third hires to presence of ensure have distributor peripheral partners clinical the our of of majority have with to launch. over field modestly on the quarter quarter before along by adding we and XXXX. direct will will coronary bring end course a XX XX Internationally, who a team to be territory to at are of specialists direct that managers planning the least most these the board
coronary time and the clinical Turning and building spent IDE CAD of III during investigator-sponsored through now year company-sponsored quarter to really. start and the clinical. research. both significant effort U.S. our XXX-patient a We quarter the evidence the was our
we XXX patients enrolled enrolment XX, completing to we had anticipate December and of in As continue March.
topic week a FDA access review on of would the FDA the this U.S. that first lead the of CX. XXXX. a approved submission to by quarter Assuming III, a for CAD earlier quarter continued third in protocol six-month and Also approval
device support additional pleased leading of safety grant CX keep the launch investigators the We to the willing of this system. it will further the the and hands commercial to efficacy to patients and was will that the us enable of in collect cohort data are to our additional up since FDA us
enrolled waiting in out study the there complete the for second our of were rate, briskly, Based December XX. patients to started on had of the quarter. cohort very XX-patient current and patients IV because start we in trial this CAD XX our Japan enrolment to as expect investigators
to continue the of be approval model mid-XXXX. timing to Japan We in
We through year restarted On PAD through side, enrollers we bigger as online the quarter. the of enrolled the this the pace approved. the some will a with sites are come documents the revised few peripheral of working get patients to November and and up arm of of also pick the III, end expect randomized getting had the logistics in
was it the patients. back year briskly We soon we with another adding new enrolled as III, required patients. the ended told XXX were no PAD was paperwork registry we registry up Since XXXX sites that and as on for over picked right
details a our few facilities operations. and with up Finishing around
space the of Our We at year. in move XXX beginning of facility was this of to going last indicated as we that by it were employee well XXXX of run CX be three our count at at if enough at XXX the having Clara today. of XX,XXX-square-foot capacity we plans the as our year. rooms Santa And does summer end completed to compared to, in middle out but risk our hiring we we the clean expect not the were to
door the us building XX,XXX-square-foot through the as new have and lease which and XXXX. of next extend both our building. the last current now Fortunately, time same been had were a into our for some enter to lease able owner to We building vacant current for
more XXXX facility square administrative supportive almost from lab expanded all to the feet. going room as And new will XXXX the R&D feet convert than an manufacturing clean building and function. to entirely as well house a current taking We're to space our building today our of square
foreseeable fortunate much We larger that the greatly and We efficient future. is to give enough opportunity since us quite available that preferred this will buildings is footprint us were space anticipate adjoining this more for support have investor this to Needless fall long-term gave by was to our make last offering than us say, to team. and the helpful the commitment. ability important more since follow-on that it had the
in on this will XXXX to will we support looks be growth. that a pace serve at put pieces we be as in we growing foundation to multiple a place and strong believe rapid where fronts the another XXXX year
like would I that call to With to turn Dan.
